| Heart disease and stroke statistics—2016 update: a report from the American Heart Association D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ... circulation 133 (4), e38-e360, 2016 | 43805* | 2016 |
| Heart disease and stroke statistics—2014 update: a report from the American Heart Association AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ... circulation 129 (3), e28-e292, 2014 | 27366* | 2014 |
| A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) CAPRIE Steering Committee The Lancet 348 (9038), 1329-1339, 1996 | 6494 | 1996 |
| An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction Gusto Investigators New England Journal of Medicine 329 (10), 673-682, 1993 | 4499 | 1993 |
| Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events DL Bhatt, KAA Fox, W Hacke, PB Berger, HR Black, WE Boden, P Cacoub, ... New England Journal of Medicine 354 (16), 1706-1717, 2006 | 3622 | 2006 |
| Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial SR Steinhubl, PB Berger, JT Mann III, ETA Fry, A DeLago, C Wilmer, ... Jama 288 (19), 2411-2420, 2002 | 3527 | 2002 |
| Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty Epic Investigators New England Journal of Medicine 330 (14), 956-961, 1994 | 2958 | 1994 |
| Risk of cardiovascular events associated with selective COX-2 inhibitors D Mukherjee, SE Nissen, EJ Topol Jama 286 (8), 954-959, 2001 | 2400 | 2001 |
| High-performance medicine: the convergence of human and artificial intelligence EJ Topol Nature medicine 25 (1), 44-56, 2019 | 2188 | 2019 |
| Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization Epilog Investigators New England Journal of Medicine 336 (24), 1689-1697, 1997 | 2100 | 1997 |
| The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction GUSTO Angiographic Investigators New England Journal of Medicine 329 (22), 1615-1622, 1993 | 2083 | 1993 |
| Prevalence of conventional risk factors in patients with coronary heart disease UN Khot, MB Khot, CT Bajzer, SK Sapp, EM Ohman, SJ Brener, SG Ellis, ... Jama 290 (7), 898-904, 2003 | 1993 | 2003 |
| Chitin chemistry GAF Roberts, GAF Roberts macmillan, 1992 | 1800 | 1992 |
| Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial SE Nissen, EM Tuzcu, P Libby, PD Thompson, M Ghali, D Garza, ... Jama 292 (18), 2217-2225, 2004 | 1782 | 2004 |
| Prevalence of asymptomatic SARS-CoV-2 infection: a narrative review DP Oran, EJ Topol Annals of internal medicine 173 (5), 362-367, 2020 | 1727 | 2020 |
| Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes PURSUIT Trial Investigators New England Journal of Medicine 339 (7), 436-443, 1998 | 1646 | 1998 |
| Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy AT Askari, S Unzek, ZB Popovic, CK Goldman, F Forudi, M Kiedrowski, ... The Lancet 362 (9385), 697-703, 2003 | 1577 | 2003 |
| Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade EJ Topol, EPISTENT Investigators The Lancet 352 (9122), 87-92, 1998 | 1518 | 1998 |
| A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease PA Gum, K Kottke-Marchant, PA Welsh, J White, EJ Topol Journal of the American College of Cardiology 41 (6), 961-965, 2003 | 1508 | 2003 |
| Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel … SG Ellis, MG Vandormael, MJ Cowley, G DiSciascio, U Deligonul, ... Circulation 82 (4), 1193-1202, 1990 | 1506 | 1990 |
